Molecular dynamics of Mycobacterium tuberculosis KasA: implications for inhibitor and substrate binding and consequences for drug design
暂无分享,去创建一个
Christoph A. Sotriffer | Benjamin Schaefer | Caroline Kisker | C. Sotriffer | C. Kisker | Benjamin J. Schaefer
[1] Klaus R. Liedl,et al. Consideration of Water and Solvation Effects in Virtual Screening , 2011 .
[2] C. Volker,et al. Purification and Biochemical Characterization of theMycobacterium tuberculosis β-Ketoacyl-acyl Carrier Protein Synthases KasA and KasB* , 2001, The Journal of Biological Chemistry.
[3] L. Kremer,et al. Conditional Depletion of KasA, a Key Enzyme of Mycolic Acid Biosynthesis, Leads to Mycobacterial Cell Lysis , 2005, Journal of bacteriology.
[4] P. Beroza,et al. Application of a pairwise generalized Born model to proteins and nucleic acids: inclusion of salt effects , 1999 .
[5] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[6] P. Kollman,et al. A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .
[7] Robert Stroud,et al. Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis. , 2006, Journal of medicinal chemistry.
[8] P. Ortiz de Montellano,et al. Correlation between isoniazid resistance and superoxide reactivity in mycobacterium tuberculosis KatG. , 2005, Journal of the American Chemical Society.
[9] C. Dye,et al. The Population Dynamics and Control of Tuberculosis , 2010, Science.
[10] David Alland,et al. Targeting Tuberculosis and Malaria through Inhibition of Enoyl Reductase , 2003, Journal of Biological Chemistry.
[11] P. Ortiz de Montellano,et al. Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides. , 2007, Bioorganic & medicinal chemistry.
[12] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[13] D Alland,et al. Thiolactomycin and Related Analogues as Novel Anti-mycobacterial Agents Targeting KasA and KasB Condensing Enzymes inMycobacterium tuberculosis * , 2000, The Journal of Biological Chemistry.
[14] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .
[15] W. C. Still,et al. Semianalytical treatment of solvation for molecular mechanics and dynamics , 1990 .
[16] Gurdyal S Besra,et al. Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis. , 2002, The Biochemical journal.
[17] C. Vilchèze,et al. Crystal Structure of the Mycobacterium tuberculosis Enoyl-ACP Reductase, InhA, in Complex with NAD+ and a C16 Fatty Acyl Substrate* , 1999, The Journal of Biological Chemistry.
[18] P. Tonge,et al. Crystal structures of Mycobacterium tuberculosis KasA show mode of action within cell wall biosynthesis and its inhibition by thiolactomycin. , 2009, Structure.
[19] P. Tonge,et al. Elucidation of the protonation states of the catalytic residues in mtKasA: implications for inhibitor design. , 2011, Biochemistry.
[20] N. Oppenheimer,et al. Structure and mechanism , 1989 .
[21] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[22] P. Tonge,et al. Slow Onset Inhibition of Bacterial β-Ketoacyl-acyl Carrier Protein Synthases by Thiolactomycin* , 2009, The Journal of Biological Chemistry.
[23] Eric Arnoult,et al. The challenge of new drug discovery for tuberculosis , 2011, Nature.
[24] Catherine Vilchèze,et al. The mechanism of isoniazid killing: clarity through the scope of genetics. , 2007, Annual review of microbiology.
[25] I. Luque,et al. Structural stability of binding sites: Consequences for binding affinity and allosteric effects , 2000, Proteins.
[26] Junmei Wang,et al. Development and testing of a general amber force field , 2004, J. Comput. Chem..
[27] P. Kollman,et al. Automatic atom type and bond type perception in molecular mechanical calculations. , 2006, Journal of molecular graphics & modelling.
[28] Jie J. Zheng,et al. The Solution Structure of Acyl Carrier Protein from Mycobacterium tuberculosis * , 2002, The Journal of Biological Chemistry.
[29] J. Ladbury. Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design. , 1996, Chemistry & biology.
[30] William R. Jacobs,et al. Microbial Pathogenesis of Mycobacterium tuberculosis: Dawn of a Discipline , 2001, Cell.
[31] G. Ciccotti,et al. Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .
[32] Jun Wang,et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties , 2006, Nature.
[33] R. Heath,et al. Inhibition of β-Ketoacyl-Acyl Carrier Protein Synthases by Thiolactomycin and Cerulenin , 2001, The Journal of Biological Chemistry.